252 related articles for article (PubMed ID: 8352177)
1. Effect of cigarette smoking on coronary patency after thrombolytic therapy for myocardial infarction. TEAM-2 Investigators. Second Multicenter Thrombolytic Trials of Eminase in Acute Myocardial Infarction.
Gomez MA; Karagounis LA; Allen A; Anderson JL
Am J Cardiol; 1993 Aug; 72(5):373-8. PubMed ID: 8352177
[TBL] [Abstract][Full Text] [Related]
2. Does thrombolysis in myocardial infarction (TIMI) perfusion grade 2 represent a mostly patent artery or a mostly occluded artery? Enzymatic and electrocardiographic evidence from the TEAM-2 study. Second Multicenter Thrombolysis Trial of Eminase in Acute Myocardial Infarction.
Karagounis L; Sorensen SG; Menlove RL; Moreno F; Anderson JL
J Am Coll Cardiol; 1992 Jan; 19(1):1-10. PubMed ID: 1729317
[TBL] [Abstract][Full Text] [Related]
3. Incomplete recanalization as an important determinant of Thrombolysis in Myocardial Infarction (TIMI) grade 2 flow after thrombolytic therapy for acute myocardial infarction. TEAM Investigators. Thrombolytic Trial of Eminase in Acute Myocardial Infarction.
Zahger D; Karagounis LA; Cercek B; Anderson JL; Sorensen S; Moreno F; Shah PK
Am J Cardiol; 1995 Oct; 76(11):749-52. PubMed ID: 7572648
[TBL] [Abstract][Full Text] [Related]
4. Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction.
Grines CL; Topol EJ; O'Neill WW; George BS; Kereiakes D; Phillips HR; Leimberger JD; Woodlief LH; Califf RM
Circulation; 1995 Jan; 91(2):298-303. PubMed ID: 7805231
[TBL] [Abstract][Full Text] [Related]
5. Influence of cigarette smoking on rate of reopening of the infarct-related coronary artery after myocardial infarction: a multivariate analysis.
de Chillou C; Riff P; Sadoul N; Ethevenot G; Feldmann L; Isaaz K; Simon JP; Boursier M; Khalifé K; Thisse JY; Aliot E
J Am Coll Cardiol; 1996 Jun; 27(7):1662-8. PubMed ID: 8636551
[TBL] [Abstract][Full Text] [Related]
6. Effects of early thrombolytic therapy (anistreplase versus streptokinase) on enzymatic and electrocardiographic infarct size in acute myocardial infarction. TEAM-2 Investigators.
Karagounis L; Moreno F; Menlove RL; Ipsen S; Anderson JL
Am J Cardiol; 1991 Oct; 68(9):848-56. PubMed ID: 1927942
[TBL] [Abstract][Full Text] [Related]
7. Multicenter patency trial of intravenous anistreplase compared with streptokinase in acute myocardial infarction. The TEAM-2 Study Investigators.
Anderson JL; Sorensen SG; Moreno FL; Hackworthy RA; Browne KF; Dale HT; Leya F; Dangoisse V; Eckerson HW; Marder VJ
Circulation; 1991 Jan; 83(1):126-40. PubMed ID: 1984877
[TBL] [Abstract][Full Text] [Related]
8. Clinical predictors of early infarct-related artery patency following thrombolytic therapy: importance of body weight, smoking history, infarct-related artery and choice of thrombolytic regimen: the GUSTO-I experience. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.
Lundergan CF; Reiner JS; McCarthy WF; Coyne KS; Califf RM; Ross AM
J Am Coll Cardiol; 1998 Sep; 32(3):641-7. PubMed ID: 9741505
[TBL] [Abstract][Full Text] [Related]
9. Multivariate associates of QT dispersion in patients with acute myocardial infarction: primacy of patency status of the infarct-related artery. TEAM-3 Investigators. Third trial of Thrombolysis with Eminase in Acute Myocardial Infarction.
Karagounis LA; Anderson JL; Moreno FL; Sorensen SG
Am Heart J; 1998 Jun; 135(6 Pt 1):1027-35. PubMed ID: 9630107
[TBL] [Abstract][Full Text] [Related]
10. TIMI perfusion grade 3 but not grade 2 results in improved outcome after thrombolysis for myocardial infarction. Ventriculographic, enzymatic, and electrocardiographic evidence from the TEAM-3 Study.
Anderson JL; Karagounis LA; Becker LC; Sorensen SG; Menlove RL
Circulation; 1993 Jun; 87(6):1829-39. PubMed ID: 8504495
[TBL] [Abstract][Full Text] [Related]
11. Gender and acute myocardial infarction: is there a different response to thrombolysis?
Woodfield SL; Lundergan CF; Reiner JS; Thompson MA; Rohrbeck SC; Deychak Y; Smith JO; Burton JR; McCarthy WF; Califf RM; White HD; Weaver WD; Topol EJ; Ross AM
J Am Coll Cardiol; 1997 Jan; 29(1):35-42. PubMed ID: 8996292
[TBL] [Abstract][Full Text] [Related]
12. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators.
Simes RJ; Topol EJ; Holmes DR; White HD; Rutsch WR; Vahanian A; Simoons ML; Morris D; Betriu A; Califf RM
Circulation; 1995 Apr; 91(7):1923-8. PubMed ID: 7895348
[TBL] [Abstract][Full Text] [Related]
13. Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial.
Cannon CP; McCabe CH; Diver DJ; Herson S; Greene RM; Shah PK; Sequeira RF; Leya F; Kirshenbaum JM; Magorien RD
J Am Coll Cardiol; 1994 Dec; 24(7):1602-10. PubMed ID: 7963104
[TBL] [Abstract][Full Text] [Related]
14. Independent impact of thrombolytic therapy and vessel patency on left ventricular dilation after myocardial infarction. Serial echocardiographic follow-up.
Popović AD; Nesković AN; Babić R; Obradović V; Bozinović L; Marinković J; Lee JC; Tan M; Thomas JD
Circulation; 1994 Aug; 90(2):800-7. PubMed ID: 8044951
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of streptokinase, but not tissue-type plasminogen activator, in achieving 90-minute patency after thrombolysis for acute myocardial infarction decreases with time to treatment. PERM Study Group. Prospective Evaluation of Reperfusion Markers.
Steg PG; Laperche T; Golmard JL; Juliard JM; Benamer H; Himbert D; Aubry P
J Am Coll Cardiol; 1998 Mar; 31(4):776-9. PubMed ID: 9525545
[TBL] [Abstract][Full Text] [Related]
16. Lack of influence of pretreatment antistreptokinase antibody on efficacy in a multicenter patency comparison of intravenous streptokinase and anistreplase in acute myocardial infarction.
Fears R; Hearn J; Standring R; Anderson JL; Marder VJ
Am Heart J; 1992 Aug; 124(2):305-14. PubMed ID: 1636574
[TBL] [Abstract][Full Text] [Related]
17. Angiographically assessed coronary arterial patency and reocclusion in patients with acute myocardial infarction treated with anistreplase: results of the anistreplase reocclusion multicenter study (ARMS).
Relik-van Wely L; Visser RF; van der Pol JM; Bartholomeus I; Couvée JE; Drost H; Vet AJ; Klomps HC; van Ekelen WA; van den Berg F
Am J Cardiol; 1991 Aug; 68(4):296-300. PubMed ID: 1858670
[TBL] [Abstract][Full Text] [Related]
18. [Indirect criteria of coronary reperfusion and permeability in patients with acute myocardial infarction who have received thrombolytic therapy].
Pereira MA; Albuquerque A; Azevedo JG; Torres S; Gomes L; Campos M; Pimenta A
Rev Port Cardiol; 1991 Mar; 10(3):229-35. PubMed ID: 1854515
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries.
Barbash GI; Reiner J; White HD; Wilcox RG; Armstrong PW; Sadowski Z; Morris D; Aylward P; Woodlief LH; Topol EJ
J Am Coll Cardiol; 1995 Nov; 26(5):1222-9. PubMed ID: 7594035
[TBL] [Abstract][Full Text] [Related]
20. Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience.
Woodfield SL; Lundergan CF; Reiner JS; Greenhouse SW; Thompson MA; Rohrbeck SC; Deychak Y; Simoons ML; Califf RM; Topol EJ; Ross AM
J Am Coll Cardiol; 1996 Dec; 28(7):1661-9. PubMed ID: 8962549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
